BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holmes-Truscott E, Skinner TC, Pouwer F, Speight J. Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: Results from Diabetes MILES - Australia cross-sectional survey. Diabet Med 2015;32:1297-303. [PMID: 25683652 DOI: 10.1111/dme.12729] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Ngassa Piotie P, Muchiri JW, Webb EM, Rheeder P. Assessing barriers to insulin therapy among people with type 2 diabetes in South Africa using the Insulin Treatment Appraisal Scale: A cross-sectional survey. Prim Care Diabetes 2022;16:509-14. [PMID: 35690550 DOI: 10.1016/j.pcd.2022.05.012] [Reference Citation Analysis]
2 Liu X, Li Y, Guan L, He X, Zhang H, Zhang J, Li J, Zhong D, Jin R. A Systematic Review and Meta-Analysis of the Prevalence and Risk Factors of Depression in Type 2 Diabetes Patients in China. Front Med (Lausanne) 2022;9:759499. [PMID: 35620713 DOI: 10.3389/fmed.2022.759499] [Reference Citation Analysis]
3 Holmes-Truscott E, Holloway EE, Husin HM, Furler J, Hagger V, Skinner TC, Speight J. Web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: study protocol for a two-armed randomised controlled trial of 'Is insulin right for me?'. BMJ Open 2022;12:e051524. [PMID: 35190420 DOI: 10.1136/bmjopen-2021-051524] [Reference Citation Analysis]
4 Hendrieckx C, de Wit M, Gray SM, van Duinkerken E, Snoek FJ. Diabetes Mellitus: A Biopsychosocial Perspective. Comprehensive Clinical Psychology 2022. [DOI: 10.1016/b978-0-12-818697-8.00206-5] [Reference Citation Analysis]
5 Ku EJ, Lee DH, Jeon HJ, Oh TK. Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study. Diabetes Res Clin Pract 2021;182:109123. [PMID: 34740742 DOI: 10.1016/j.diabres.2021.109123] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Arda Sürücü H, Okur Arslan H, Çetik S. Self-care, A1C and stigmatization as predictors of a negative perception of insulin among adults with type 2 diabetes: a hospital-based study in Turkey. JHR 2020;35:515-26. [DOI: 10.1108/jhr-12-2019-0298] [Reference Citation Analysis]
7 Chen CC, Li TC, Huang CY, Chang MP. Validation of the Chinese version of the insulin treatment appraisal scale. Diabetes Res Clin Pract 2020;170:108485. [PMID: 33035596 DOI: 10.1016/j.diabres.2020.108485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sharma SK, Kant R, Kalra S, Bishnoi R. Prevalence of Primary Non-adherence with Insulin and Barriers to Insulin Initiation in Patients with Type 2 Diabetes Mellitus - An Exploratory Study in a Tertiary Care Teaching Public Hospital. Eur Endocrinol 2020;16:143-7. [PMID: 33117446 DOI: 10.17925/EE.2020.16.2.143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cunningham SM, Tanner DA. A Review: The Prospect of Inhaled Insulin Therapy via Vibrating Mesh Technology to Treat Diabetes. Int J Environ Res Public Health 2020;17:E5795. [PMID: 32785196 DOI: 10.3390/ijerph17165795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Choi S, Kim SH. Influences of Patient Activation on Diabetes Self-Care Activities and Diabetes-Specific Distress. Korean J Adult Nurs 2020;32:10. [DOI: 10.7475/kjan.2020.32.1.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Winkley K, Upsher R, Polonsky WH, Holmes-Truscott E. Psychosocial aspects and contributions of behavioural science to medication-taking for adults with type 2 diabetes. Diabet Med 2020;37:427-35. [PMID: 31837158 DOI: 10.1111/dme.14214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Cheng LJ, Wu VX, Dawkes S, Lim ST, Wang W. Factors influencing diet barriers among outpatients with poorly-controlled type 2 diabetes: A descriptive correlational study. Nurs Health Sci 2019;21:102-11. [PMID: 30264523 DOI: 10.1111/nhs.12569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ku EJ, Lee DH, Jeon HJ, Oh TK. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice. Diabetes Obes Metab 2019;21:173-7. [PMID: 30039538 DOI: 10.1111/dom.13476] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
14 Jeon HJ, Ku EJ, Oh TK. Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control. Diabetes Research and Clinical Practice 2018;142:188-94. [DOI: 10.1016/j.diabres.2018.05.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Holmes-truscott E, Browne JL, Ventura AD, Pouwer F, Speight J. Diabetes stigma is associated with negative treatment appraisals among adults with insulin-treated Type 2 diabetes: results from the second Diabetes MILES - Australia (MILES-2) survey. Diabet Med 2018;35:658-62. [DOI: 10.1111/dme.13598] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
16 Wardian JL, Tate J, Folaron I, Graybill S, True M, Sauerwein T. Who's distressed? A comparison of diabetes-related distress by type of diabetes and medication. Patient Educ Couns 2018;101:1490-5. [PMID: 29525142 DOI: 10.1016/j.pec.2018.03.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Nefs G, Pouwer F. The role of hypoglycemia in the burden of living with diabetes among adults with diabetes and family members: results from the DAWN2 study in The Netherlands. BMC Public Health 2018;18:156. [PMID: 29347915 DOI: 10.1186/s12889-018-5064-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
18 Russell-Jones D, Pouwer F, Khunti K. Identification of barriers to insulin therapy and approaches to overcoming them. Diabetes Obes Metab. 2018;20:488-496. [PMID: 29053215 DOI: 10.1111/dom.13132] [Cited by in Crossref: 122] [Cited by in F6Publishing: 127] [Article Influence: 24.4] [Reference Citation Analysis]
19 Browne JL, Holmes-Truscott E, Ventura AD, Hendrieckx C, Pouwer F, Speight J. Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES-Australia (MILES-2) study. BMJ Open 2017;7:e012926. [PMID: 28246132 DOI: 10.1136/bmjopen-2016-012926] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
20 Bramlage P, Bluhmki T, Fleischmann H, Kaltheuner M, Beyersmann J, Holl RW, Danne T. Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry. BMJ Open Diabetes Res Care 2017;5:e000301. [PMID: 28176957 DOI: 10.1136/bmjdrc-2016-000301] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Holmes-truscott E, Browne JL, Speight J. The impact of insulin therapy and attitudes towards insulin intensification among adults with type 2 diabetes: A qualitative study. Journal of Diabetes and its Complications 2016;30:1151-7. [DOI: 10.1016/j.jdiacomp.2016.03.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
22 Tanenbaum ML, Kane NS, Kenowitz J, Gonzalez JS. Diabetes distress from the patient's perspective: Qualitative themes and treatment regimen differences among adults with type 2 diabetes. J Diabetes Complications 2016;30:1060-8. [PMID: 27217023 DOI: 10.1016/j.jdiacomp.2016.04.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
23 Holmes-Truscott E, Blackberry I, O'Neal DN, Furler JS, Speight J. Willingness to initiate insulin among adults with type 2 diabetes in Australian primary care: Results from the Stepping Up Study. Diabetes Res Clin Pract 2016;114:126-35. [PMID: 26818893 DOI: 10.1016/j.diabres.2015.12.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
24 Cheng L, Leung DY, Sit JW, Li XM, Wu YN, Yang MY, Gao CX, Hui R. Factors associated with diet barriers in patients with poorly controlled type 2 diabetes. Patient Prefer Adherence 2016;10:37-44. [PMID: 26834464 DOI: 10.2147/PPA.S94275] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
25 Pittas AG, Westcott GP, Balk EM. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:886-894. [PMID: 26341170 DOI: 10.1016/s2213-8587(15)00280-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]